Hematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousUnrelated DonorsGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousTissue DonorsStem CellsPeripheral Blood Stem Cell TransplantationHistocompatibility TestingBone Marrow TransplantationHematologic NeoplasmsHistocompatibilityCord Blood Stem Cell TransplantationGraft SurvivalTreatment OutcomeLiver TransplantationTransplantation ChimeraMyeloablative AgonistsHematopoietic Stem CellsRecurrenceLiving DonorsMesenchymal Stem Cell TransplantationWhole-Body IrradiationKidney TransplantationBusulfanLeukemiaHLA AntigensRetrospective StudiesImmunosuppressive AgentsVidarabineCell TransplantationEmbryonic Stem CellsDisease-Free SurvivalSurvival AnalysisRemission InductionBlood DonorsSurvival RateMelphalanSiblingsAdult Stem CellsCombined Modality TherapyAnemia, AplasticAntilymphocyte SerumTransplantation ImmunologyMultiple MyelomaGraft vs Leukemia EffectGraft RejectionHematopoietic Stem Cell MobilizationHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteTime FactorsDonor SelectionMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHeart TransplantationCyclophosphamideLymphocyte DepletionPluripotent Stem CellsGraft vs Tumor EffectCell DifferentiationSalvage TherapyHepatic Veno-Occlusive DiseaseChimerismAntigens, CD34Lung TransplantationFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsAcute DiseaseLymphocyte TransfusionTransplantation, IsogeneicStem Cell NicheNeural Stem CellsMesenchymal Stromal CellsImmunosuppressionFetal BloodOrgan TransplantationCytomegalovirus InfectionsCyclosporineInduced Pluripotent Stem CellsGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinInfectionTransplantationPrognosisT-LymphocytesSevere Combined ImmunodeficiencyHematopoiesisIslets of Langerhans TransplantationMultipotent Stem CellsCytarabineAllograftsTissue and Organ ProcurementRisk FactorsBone Marrow CellsCells, CulturedFetal Stem CellsTacrolimus